Alaunos Therapeutics, Inc. SEC filings TCRT
Alaunos Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 1, 2010. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 22, 2026 | Sep 18, 2026 |
| 424B3 | Prospectus | Sep 21, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 17, 2026 | Sep 16, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| S-8 | Employee stock plan registration | Jul 6, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Other events
|
May 18, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 15, 2026 | Apr 9, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Agreement ended, Change to shareholder rights, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 17, 2025 |
| 424B8 | Filing | Dec 11, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| S-3/A | Filing | Nov 7, 2025 | — |
| S-1 | Registration statement | Oct 22, 2025 | — |
| S-3/A | Filing | Oct 2, 2025 | — |
| CORRESP | Letter to the SEC | Oct 1, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2025 | — |
| S-3/A | Filing | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2025 | — |
| S-3 | Shelf registration | Aug 21, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 20, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results
|
Jul 10, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jul 2, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 26, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jun 26, 2025 | Jun 24, 2025 |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 10, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 23, 2025 | May 19, 2025 |
| ARS | Annual report to shareholders | May 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 21, 2025 | — |
| DEF 14A | Proxy statement | May 21, 2025 | Jul 3, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | May 9, 2025 | Jul 3, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 18, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Apr 14, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 11, 2025 | Apr 7, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Agreement ended, Results of operations
|
Oct 10, 2024 | Oct 4, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 17, 2024 | Jul 16, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jul 17, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Other events
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 21, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 6, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 6, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Feb 20, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 1, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2024 | Jan 20, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 2, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 28, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Results of operations, Listing notice
|
Nov 14, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2023 | Sep 22, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 6, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 4, 2023 | Apr 3, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 3, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 7, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 30, 2022 | Nov 28, 2022 |
| 424B5 | Prospectus supplement | Nov 30, 2022 | — |
| 424B5 | Prospectus supplement | Nov 28, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Other events
|
Sep 30, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 21, 2022 | Sep 21, 2022 |
| EFFECT | Filing | Sep 7, 2022 | — |
| 424B5 | Prospectus supplement | Sep 7, 2022 | — |
| 8-K |
Current report
Other events
|
Sep 6, 2022 | Sep 6, 2022 |
| CORRESP | Letter to the SEC | Sep 2, 2022 | — |
| S-3/A | Filing | Aug 31, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 24, 2022 | Aug 24, 2022 |
| UPLOAD | Letter from the SEC | Aug 19, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| S-3 | Shelf registration | Aug 12, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 13, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 27, 2022 | Jun 24, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 2, 2022 | May 2, 2022 |
| 8-K |
Current report
Other events
|
May 2, 2022 | May 2, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 13, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 13, 2022 |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 18, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 17, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jan 26, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 4, 2022 | Dec 28, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2021 | Aug 30, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 12, 2021 | Aug 6, 2021 |
| NT 10-Q | Filing | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
May 21, 2021 | May 17, 2021 |
| 8-K |
Current report
Officer or director change
|
May 13, 2021 | May 7, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2021 | Apr 5, 2021 |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEF 14A | Proxy statement | Apr 7, 2021 | May 19, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2021 | May 19, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 22, 2021 |
| SEC STAFF LETTER | Filing | Mar 11, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2021 | Feb 24, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2021 | Feb 17, 2021 |
| SEC STAFF LETTER | Filing | Feb 10, 2021 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Feb 5, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2021 | Jan 14, 2021 |
| 8-K |
Current report
Listing notice
|
Dec 30, 2020 | Dec 28, 2020 |
| 8-K |
Current report
Listing notice, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Dec 18, 2020 | Dec 15, 2020 |
| DFAN14A | Filing | Dec 17, 2020 | — |
| DEFA14A | Additional proxy material | Dec 17, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2020 | Dec 10, 2020 |
| DFAN14A | Filing | Dec 14, 2020 | — |
| DEFA14A | Additional proxy material | Dec 14, 2020 | — |
| DEFA14A | Additional proxy material | Dec 11, 2020 | — |
| DFAN14A | Filing | Dec 8, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2020 | Dec 3, 2020 |
| DEFA14A | Additional proxy material | Dec 4, 2020 | — |
| DEFA14A | Additional proxy material | Dec 4, 2020 | — |
| DFAN14A | Filing | Dec 3, 2020 | — |
| DFAN14A | Filing | Dec 2, 2020 | — |
| DEFA14A | Additional proxy material | Nov 30, 2020 | — |
| DFAN14A | Filing | Nov 30, 2020 | — |
| DEFA14A | Additional proxy material | Nov 27, 2020 | — |
| DEFA14A | Additional proxy material | Nov 27, 2020 | — |
| DFAN14A | Filing | Nov 27, 2020 | — |
| DFAN14A | Filing | Nov 24, 2020 | — |
| DFAN14A | Filing | Nov 23, 2020 | — |
| DEFA14A | Additional proxy material | Nov 20, 2020 | — |
| DEFA14A | Additional proxy material | Nov 20, 2020 | — |
| DEFA14A | Additional proxy material | Nov 19, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2020 | Nov 15, 2020 |
| DFAN14A | Filing | Nov 19, 2020 | — |
| DFAN14A | Filing | Nov 18, 2020 | — |
| DFAN14A | Filing | Nov 16, 2020 | — |
| DFAN14A | Filing | Nov 13, 2020 | — |
| DFAN14A | Filing | Nov 12, 2020 | — |
| DFAN14A | Filing | Nov 5, 2020 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2020 | Nov 5, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| DFRN14A | Filing | Nov 4, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DFAN14A | Filing | Nov 2, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DEFC14A | Filing | Nov 2, 2020 | — |
| DEFC14A | Filing | Oct 30, 2020 | — |
| PRRN14A | Filing | Oct 29, 2020 | — |
| PRRN14A | Filing | Oct 28, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TCRT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1107421
- Former names
- ZIOPHARM ONCOLOGY INC (until Jan 4, 2022); EASYWEB INC (until Sep 19, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.